Longbow Advantage Inc. – Trademark Portfolio
Entity Type: 03
Longbow Advantage Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include REBUS. The owner is based in Montréal, QUEBEC.
7250 Mile End Street, Suite #201
Montréal, QUEBEC H2R3A4 , CA
Showing of trademarks Trademarks
Trademark Classifications
Longbow Advantage Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Longbow Advantage Inc. have?
Longbow Advantage Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Longbow Advantage Inc. file in?
Longbow Advantage Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Longbow Advantage Inc.'s most well-known trademarks?
Longbow Advantage Inc.'s registered trademark portfolio includes well-known marks such as REBUS. These are among 1 currently registered trademark in the portfolio.
What is Longbow Advantage Inc.'s trademark registration success rate?
Longbow Advantage Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.